IDH2 and central nervous system cancer: Consistent with the recent report of more chromosome gains in regions containing RTK pathways in IDH-wildtype gliomas [21], this finding suggests a weakened RTK signaling in IDH-mutant glioma compared with IDH-wildtype glioma, as suggested previously [2].